Dr. Khadijah Dashti | Biomedical and Healthcare Applications | Best Researcher Award

Dr. Khadijah Dashti | Biomedical and Healthcare Applications | Best Researcher Award

Doctorate at Kuwait University | Kuwait

Dr. Khadijah Mohammed Dashti is a distinguished academic and researcher in the field of Medical Microbiology and Antimicrobial Agents. She currently serves as an Assistant Professor at the Faculty of Allied Health Sciences, Kuwait University, where she has been a faculty member since 2023. With extensive expertise in microbial diseases and innovative approaches to antibiotic discovery, Dr. Dashti is a leading figure in her field.

Professional Profile

Scopus

🎓Academic Qualifications 

Dr. Khadijah Mohammed Dashti holds a rich academic background in Medical Laboratory Sciences and Biomedical Sciences. She completed her Bachelor’s Degree (B.Sc.) in Medical Laboratory Sciences at Kuwait University in 2011, where her research project investigated “The prevalence of plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli in Kuwait.”Her academic journey continued with two Master’s Degrees (M.Sc.). The first, in Biomedical Sciences, was awarded by the University of Westminster in 2015, with her thesis focusing on “The effect of heavy metals on biofilm formed by Pseudomonas aeruginosa.” The second, in Medical Laboratory Sciences, was earned at Kuwait University in 2016, and her thesis explored “The Prevalence of Multidrug-resistant Acinetobacter baumannii in Kuwait and Typing of the Isolates by MLST.”

Dr. Dashti achieved her Ph.D. in Microbial Diseases and Antimicrobial Agents from University College London in 2023. Her doctoral research, titled “Natural Antibiotic Discovery,” reflects her profound dedication to finding innovative solutions to combat antimicrobial resistance.

🧪Academic Experience and Achievements 

Dr. Dashti has been actively involved in academic mentorship, having supervised four B.Sc. student projects since 2023. These projects explored diverse topics such as the antibacterial potential of colistin-resistant Escherichia coli, the use of garlic and essential oils in combating resistance, and the discovery of novel antibacterials by mining Pseudomonas aeruginosa genomes. Her guidance and expertise have fostered critical research in microbial sciences.She has also attended and benefited from workshops such as the Bioinformatics course and the How to Write a Good Dissertation/Thesis session, both presented by Prof. Sebastian Amyes at Kuwait University, further enhancing her academic and mentorship capabilities.

🔬Research Interests 

Dr. Dashti’s research interests center on understanding and combating pathogenic microorganisms and antibiotic resistance. She investigates the mechanisms of drug resistance in critical pathogens such as Staphylococci/MRSA and ESKAPE pathogens, aiming to develop novel antibacterial methods. Her work also delves into understanding host-bacteria interactions, focusing on their dynamics in health and disease. A key area of her current research is the identification of new sources of antibiotic-producing bacteria to address global challenges in infectious disease treatment.

🌍Memberships and Affiliations 

A dedicated professional, Dr. Dashti is an active member of the Society for Applied Microbiology (SfAM) and the Microbiology Society, maintaining her affiliation with both organizations since 2016.

🧠Skills and Expertise 

Dr. Dashti possesses advanced skills in bioinformatics, antimicrobial resistance, and microbial pathogenicity. Her strong expertise in antibiotic discovery and development of novel antibacterial techniques underscores her commitment to addressing infectious diseases. Furthermore, her proficiency in academic supervision, research project guidance, and publication of high-quality research demonstrates her multifaceted expertise in microbial sciences.Dr. Khadijah Mohammed Dashti’s significant contributions to antimicrobial research and her dedication to mentoring future scientists make her an inspiring figure in the field of microbiology.

Publications Top Noted📚

Genetic landscape and clinical outcomes of autosomal recessive polycystic kidney disease in Kuwait

Authors: Alhaddad, M.E., Mohammad, A., Dashti, K.M., Al-Ali, M., Ali, H.
Journal: Heliyon
Year: 2024

Diversity of multi-drug resistant Acinetobacter baumannii population in a major hospital in Kuwait

Authors: Vali, L., Dashti, K., Opazo-Capurro, A.F., Al Obaid, K., Evans, B.A.
Journal: Frontiers in Microbiology
Year: 2015

Dr. Nina Sharp | Healthcare Applications | Best Researcher Award

Dr. Nina Sharp | Healthcare Applications | Best Researcher Award

Doctorate at Arizona State University, United States

Profiles

Scopus

Orcid

Google Sholar

Education

  • Ph.D. in Architecture, University of Illinois at Urbana-Champaign (2020)
  • Master of Architecture, University of Illinois at Urbana-Champaign (2016)
  • M.S. in Architectural Engineering, Iran University of Science and Technology (2011)
  • B.S. in Architectural Engineering, Iran University of Science and Technology (2009)

🏛️ Academic Appointments

  • Assistant Professor, The Design School, Arizona State University (2021-present)
  • Research Affiliate, Mayo Clinic, Phoenix, AZ (2023-present)
  • Senior Global Futures Scientist, Julie Ann Wrigley Global Futures Laboratory (2022-present)
  • Assistant Professor, School of Human Ecology, University of Wisconsin, Madison (2020-2021)
  • Adjunct Faculty, Interior Design Department, Maryville University (2018-2019)

🔬 Research Interests

Dr. Sharp’s research intersects architecture, environmental design, and healthcare, focusing on the impact of lighting and thermal environments on cognitive performance, health, and well-being, particularly in older adults and clinical settings. She has secured multiple research grants, including projects funded by the National Institute on Aging and the National Science Foundation.

🏆 Honors and Awards

  • 2023 Best Oral Contribution Award, Healthy Buildings Europe Conference
  • 2023 The Design School Knowledge Enterprise Award
  • 2020 ARCC Dissertation Award
  • Multiple scholarships and fellowships from the Illuminating Engineering Society and University of Illinois.

🛠️ Professional Development

  • 2023 ASU NSF I-Corps Five-Week Training Program
  • 2022 Daylight Awareness Week, Velux
  • 2021 Partnership for Innovation, National Science Foundation

 

Publications

Photophobia is associated with lower sleep quality in individuals with migraine: results from the American Registry for Migraine Research (ARMR)

  • Authors: Nina Sharp, Mark J Burish, Kathleen B Digre, Jessica Ailani, Mahya Fani, Sophia Lamp, Todd J Schwedt
  • Journal: The Journal of Headache and Pain
  • Year: 2024

Exploring Methodological Considerations: A Literature Review on How Lighting Affects the Sleep and Cognition in Healthy Older Adults

  • Authors: Mahya Fani, Nina Sharp
  • Journal: Journal of Daylighting
  • Year: 2024

Lighting up living spaces to improve mood and cognitive performance in older adults

  • Authors: Nastaran Shishegar, Mohamed Boubekri
  • Journal: Journal of Environmental Psychology
  • Year: 2022

An Investigation of Light Spectrum and Intensity on Depression among Older Adults

  • Authors: Mohamed Boubekri, Nina Sharp
  • Journal: Journal ISSN
  • Year: 2023

Tuning environmental lighting improves objective and subjective sleep quality in older adults

  • Authors: Nastaran Shishegar, Mohamed Boubekri, Elizabeth AL Stine-Morrow, Wendy A Rogers
  • Journal: Building and Environment
  • Year: 2021

Prof Dr. Michael Linnebacher | Healthcare Applications | Best Researcher Award

Prof Dr. Michael Linnebacher | Healthcare Applications | Best Researcher Award

Prof Doctorate at Universitätsmedizin Rostock, Germany 

Profiles

Scopus

Orcid

Summary:

Prof Dr. Michael Linnebacher, born on July 5, 1969, in Ottweiler, Germany, is a prominent researcher in molecular oncology and immunotherapy. He serves as the Laboratory and Research Director at the Clinic for General Surgery, University Medicine Rostock. Linnebacher’s career spans significant contributions to the understanding and treatment of gastrointestinal tumors, particularly focusing on immunotherapy and the role of microsatellite instability in cancer.

Education

Prof Dr. Linnebacher holds a Diploma in Biology from the University of Saarland (1996) and completed his PhD in Biology at the Technical University of Karlsruhe in 2001. His academic training includes extensive research on immunogenic neo-peptides and tumor antigens, setting a strong foundation for his career in oncology and immunotherapy.

💼 Professional Experience

  • 1996-1997: Research assistant, Heidelberg University Biochemistry Center
  • 1998-2001: PhD student, Institute of Immunology, Ruprecht-Karls-University Heidelberg
  • 2001-2005: Postdoctoral research, University Hospital Heidelberg, Department of Molecular Pathology
  • 2005-Present: Laboratory Director, Molecular Oncology and Immunotherapy, Clinic for General Surgery, University Medical Center Rostock
  • 2009: Venia legendi (Privatdozent)
  • 2010: Junior Professor for Immunology and Infectiology, University of Saarland
  • 2012: Professor for Translational Surgical Oncology and Biobanking, University of Lübeck
  • 2020-Present: Managing Director, BioBank Rostock; Member of the German Biobank Alliance

🔬 Research Interests

  • Immunotherapy and its applications in cancer treatment
  • Microsatellite instability and its role in tumor antigen development
  • Translational research in oncology
  • Biobanking and its role in cancer research and treatment

 

Publications

Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells

  • Authors: Schwarz, S., Su, Z., Krohn, M., Schlosser, A., Linnebacher, M.
  • Journal: npj Precision Oncology
  • Year: 2024
  • Authors: Edelmann, M., Fan, S., De Oliveira, T., Rieken, S., Conradi, L.-C.
  • Journal: Cancer Research Communications
  • Year: 2024

Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer

  • Authors: Mariella, E., Grasso, G., Miotto, M., Di Nicolantonio, F., Bardelli, A.
  • Journal: Molecular Oncology
  • Year: 2024

SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation

  • Authors: Yuan, J., Zhu, Z., Zhang, P., Gong, P., Zhang, X.
  • Journal: Cancer Letters
  • Year: 2024

A glutamatergic biomarker panel enables differentiating Grade 4 gliomas/astrocytomas from brain metastases

  • Authors: Lange, F., Gade, R., Einsle, A., Freiman, T.M., Kirschstein, T.
  • Journal: Frontiers in Oncology
  • Year: 2024

Prof. Yaser Elewa | Healthcare Applications | Best Researcher Award

Prof. Yaser Elewa | Healthcare Applications | Best Researcher Award

Professor at Hokkaido University, Japan

Profiles

Scopus

Orcid

🎓 Academic Background & Education

Professor Yaser H. A. Elewa is a distinguished Professor of Histology and Cell Biology (currently on Sabbatical leave) at the Department of Histology, Faculty of Veterinary Medicine, Zagazig University, Egypt. He obtained his Ph.D. in Histology and Cell Biology in April 2011 through a prestigious channel system scholarship between Hokkaido University, Japan, and Zagazig University, Egypt. Prior to that, he completed his Master’s degree in April 2006, focusing on immunological organs in Ostrich, from the same department. He holds a Bachelor’s degree in Veterinary Medical Sciences, graduating with honors in 2001.

💼 Professional Experience

Prof. Elewa has held several academic positions, including his current role as a Professor at Zagazig University since April 2021. He has also been a Tenure-track Assistant Professor at the Department of Biomedical Science, Faculty of Veterinary Medicine, Hokkaido University, Japan, since February 2017. His extensive teaching experience spans various subjects, including Anatomy, Histology, and Cellular Biology, where he has developed and delivered specialized curriculum and laboratory experiments for undergraduate, graduate, and postdoctoral students.

🔬 Research Interests & Expertise

With a deep passion for research, Prof. Elewa’s interests lie in areas such as Mucosa-associated lymphoid tissue, Mediastinal fat-associated lymphoid clusters, and Immunity—both innate and adaptive. His expertise extends to Histopathology, Immunohistochemistry, Immunofluorescence, Flow Cytometry, and advanced microscopic techniques, including Transmission and Scanning Electron Microscopy. His research has contributed significantly to understanding respiratory diseases, intrathoracic immune hemostasis, autoimmunity, kidney diseases, and reproductive disorders.

🏅 Awards & Recognition

Throughout his career, Prof. Elewa has been honored with numerous awards and scholarships, including the prestigious Japanese Society for the Promotion of Science (JSPS) post-doctoral fellowship. He has also been recognized with the Best Research Award by the Faculty of Veterinary Medicine, Zagazig University.

📚 Workshops & Training

To further enhance his knowledge and skills, Prof. Elewa has participated in various workshops and training programs. These include training on Nanoparticles at the Institute for the Advancement of Higher Education, Japan, Real-Time PCR Applications at Hokkaido University, and Advanced Analytical Machines usage, including Flow Cytometry, also at Hokkaido University.

🌍 International Experience

Prof. Elewa’s international exposure includes multiple research visits and collaborations, particularly with institutions in Japan, where he has served as a post-doctoral visiting researcher and trained international students in advanced histopathological techniques.

 

Publications

Expression Patterns of Grainyhead-Like 2 and Ovo-Like 2 in Mouse Mammary Gland Development During Pregnancy, Lactation, and Weaning

  • Authors: Elfeky, M., Matsuoka, S., Yamamoto, I., Okamatu-Ogura, Y., Kimura, K.
  • Journal: Microscopy and Microanalysis
  • Year: 2024

Sleep disorders cause Parkinson’s disease or the reverse is true: Good GABA good night

  • Authors: Al-kuraishy, H.M., Al-Gareeb, A.I., Albuhadily, A.K., Zahran, M.H., Batiha, G.E.-S.
  • Journal: CNS Neuroscience and Therapeutics
  • Year: 2024

In vivo investigation of the anti-liver fibrosis impact of Balanites aegyptiaca/chitosan nanoparticles

  • Authors: Zein, N., Yassin, F., Ayoub, H.G., Batiha, G.E.-S., Zahran, M.H.
  • Journal: Biomedicine and Pharmacotherapy
  • Year: 2024

Diosgenin alleviates D-galactose-induced oxidative stress in rats’ brain and liver targeting aging and apoptotic marker genes

  • Authors: El-Far, A.H., Elghaity, M.M., Mohamed, S.A., Al Jaouni, S.K., Alsenosy, A.A.
  • Journal: Frontiers in Molecular Biosciences
  • Year: 2024

Harnessing Topology and Stereochemistry of Glycidylamine-Derived Lipid Nanoparticles for in Vivo mRNA Delivery to Immune Cells in Spleen and Their Application for Cancer Vaccination

  • Authors: Abd Elwakil, M.M., Suzuki, R., Khalifa, A.M., Satoh, T., Harashima, H.
  • Journal: Advanced Functional Materials
  • Year: 2023

Dr. Yongkui Ren | Healthcare Applications | International Visionary in Computer Vision Award

Dr. Yongkui Ren | Healthcare Applications | International Visionary in Computer Vision Award

Doctorate at The First Affiliated Hospital of Dalian Medical University, China

Profile

Scopus

📋 Summary

Dr. Yongkui Ren, a distinguished cardiovascular specialist, is currently 38 years old. He serves as the Associate Chief Physician in the Department of Cardiovascular Medicine at The First Affiliated Hospital of Dalian Medical University, Dalian, China.

Education

Dr. Ren obtained his MD from Capital Medical University in Beijing, China. He completed his Master’s and Bachelor’s degrees at China Medical University in Shenyang, China, specializing in cardiovascular research and clinical practice.

🩺 Professional and Teaching Experience

Dr. Ren’s medical career began as a resident doctor in the Department of Cardiovascular Medicine at The First Affiliated Hospital of Dalian Medical University. Over the years, he advanced to Attending Physician and currently holds the position of Associate Chief Physician. His extensive experience in cardiovascular medicine has made him a valuable asset to his department.

🏥 Professional Society Membership

Dr. Ren is an active member of the Hypertension Prevention and Control Professional Committee of the Liaoning Primary Health Association, contributing to advancements in hypertension management and control.

🔬 Research Experience

Dr. Ren’s research journey began during his Master’s degree, focusing on myocardial ischemia-reperfusion injury. He continued his research at The First Affiliated Hospital of Dalian Medical University, where he successfully applied for grants and participated in significant multi-center clinical trials. His recent work during his Ph.D. involves the analysis of medical big data using machine learning methods for cohort analysis and prediction.

🔭 Future Research Directions:

Dr. Ren aims to further investigate the mechanisms behind coronary artery calcification and its progression. He is also interested in identifying markers related to coronary calcification and exploring their mechanisms through basic research. Additionally, he plans to leverage advanced statistical methods, such as R language and machine learning, for data mining and participate in multi-center clinical trials.

 

Publications

Mediating Effect of the NLR on the Relationship between HbA1c and Left Atrial Stiffness in Overweight Patients with Hypertension

  • Authors: Zhang, R., Pan, Y., Ren, Y.K., Liu, Y., Jiang, Y.N.
  • Journal: American Journal of Hypertension
  • Year: 2024

Diagnostic accuracy of a novel optical coherence tomography-based fractional flow reserve algorithm for assessment of coronary stenosis significance

  • Authors: Pan, W., Wei, W., Hu, Y., Leng, X., Yin, D.
  • Journal: Cardiology Journal
  • Year: 2024

Predictive value of machine learning algorithm of coronary artery calcium score and clinical factors for obstructive coronary artery disease in hypertensive patients

  • Authors: Wang, M., Sun, M., Yu, Y., Ren, Y., Yin, D.
  • Journal: BMC Medical Informatics and Decision Making
  • Year: 2023

Triglyceride glucose index is associated with obstructive coronary artery disease in hypertensive patients

  • Authors: Pan, W., Ren, Y., Yang, F., Li, X., Yin, D.
  • Journal: Cardiovascular Diabetology
  • Year: 2023

Association of triglyceride glucose index levels ​​with calcification patterns and vulnerability of plaques: an intravascular ultrasound study

  • Authors: Yin, D., Wang, M., Liu, X., Ren, Y., Liu, J.
  • Journal: International Journal of Cardiovascular Imaging
  • Year: 2023

Dr. Yuki Higashimoto | Healthcare Applications | Best Researcher Award

Dr. Yuki Higashimoto | Healthcare Applications | Best Researcher Award

Doctorate at Fujita Health University, Japan

Profiles

Orcid

Education

Dr. Yuki completed his primary education with 6 years in primary school, followed by 3 years in junior high school and 3 years in senior high school. He pursued his university education at Fujita Health University School of Health Sciences from 2003 to 2007. He continued his graduate studies at Fujita Health University Graduate School of Health Sciences, earning his Master’s degree from 2007 to 2009. He later obtained his Doctor of Philosophy in Medicine (PhD) in September 2018 from the Graduate School of Medicine, Fujita Health University.

Professional Experience

From 2009 to 2017, Dr. Yuki worked as a Medical Technologist in the Department of Clinical Laboratory at Fujita Health University Hospital, Toyoake, Aichi, Japan. He served as an Assistant Professor at the Faculty of Medical Technology, Fujita Health University, from 2017 to August 2021. Additionally, he continued as a Medical Technologist at Fujita Health University Hospital until 2022.

📚 Teaching and Academic Appointments

Since September 2021, Dr. Yuki has held the position of Senior Assistant Professor of Clinical Microbiology and Clinical Immunology at the Faculty of Medical Technology, Fujita Health University, Toyoake, Aichi, Japan.

🏆 Honors and Awards

In 2018, Dr. Yuki received the Young Scientist Incentive Award from The Japanese Society of Clinical Virology.

🔬 Professional Memberships

Dr. Yuki is an active member of several professional organizations, including The Japanese Society for Virology, The Japanese Society of Clinical Virology, The Japanese Society of Vaccinology, The Japanese Society for Clinical Microbiology, The Japan Association for Clinical Laboratory Science, and the Japanese Society of Food Science and Risk Analysis.

 Publications

Generation of Recombinant Authentic Live Attenuated Human Rotavirus Vaccine Strain RIX4414 (Rotarix<sup>®</sup>) from Cloned cDNAs Using Reverse Genetics
  • Authors: Saori Fukuda, Masanori Kugita, Kanako Kumamoto, Yuki Akari, Yuki Higashimoto, Shizuko Nagao, Takayuki Murata, Tetsushi Yoshikawa, Koki Taniguchi, Satoshi Komoto
  • Journal: Viruses
  • Year: 2024
Andrographolide, isolated from Andrographis paniculata, induces apoptosis in monocytic leukemia and multiple myeloma cells via augmentation of reactive oxygen species production
  • Authors: Doi H, Matsui T, Dijkstra JM, Ogasawara A, Higashimoto Y, Imamura S, Ohye T, Takematsu H, Katsuda I, Akiyama H
  • Journal: F1000Research
  • Year: 2021
Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection
  • Authors: Inaba M, Higashimoto Y, Toyama Y, Horiguchi T, Hibino M, Iwata M, Imaizumi K, Doi Y
  • Journal: International Journal of Infectious Diseases
  • Year: 2021
Evaluation of varicella vaccine effectiveness during outbreaks in schools or nurseries by cross-sectional study
  • Authors: Kawamura Y, Hattori F, Higashimoto Y, Kozawa K, Yoshikawa T
  • Journal: Vaccine
  • Year: 2021
Dry loop–mediated isothermal amplification assay for detection of SARS-CoV-2 from clinical specimens
  • Authors: Higashimoto Y, Ihira M, Kawamura Y, Inaba M, Shirato K, Suzuki T, Hasegawa H, Kageyama T, Doi Y, Hata T et al.
  • Journal: Preprint
  • Year: 2020